[Indications for positron emission tomography (pet): a brief update]

Rossignol M
Record ID 32011000448
Authors' objectives: The purpose of this report is to provide an initial response to various questions concerning the expansion of the clinical indications for positronemission tomography (PET) and PET-CT in oncology and for other types of diseases with regard to the current practice in Quebec
Authors' recommendations: The range of new or expanded indications for PET in relation to those currently accepted in Qu├ębec remains fairly limited. However, PET is a rapidly evolving technology, and its combined use with other technologies such as magnetic resonance imaging, is opening development prospects for new clinical applications.
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Positron-Emission Tomography
Organisation Name: Institut national d'excellence en sante et en services sociaux
Contact Address: L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name: demande@inesss.qc.ca
Contact Email: demande@inesss.qc.ca
Copyright: L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.